Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.

On the 25th, in front of a growth clinic in Seocho District, Seoul. A 10-year-old girl surnamed Park came out after finishing a consultation with her grandmother. The grandmother repeatedly told her ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya® (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

What is Inluryo, and who can benefit from it? Learn about this newly approved breast cancer treatment and how it works.

However, men with higher PSA levels did show modest improvements in survival, suggesting that hormone therapy might be worthwhile for them. PSA (prostate-specific antigen) is produced by the prostate ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: Enclomiphene boosts natural testosterone production by stimulating the hypothalamic-pituitary-gonadal (HPG) axis, making it a ...

Americans who have traveled to Europe notice a difference in ingredients, which raises the question of why some U.S. foods ...

Navepegritide is indicated for those ages 2 and older with open epiphyses ...

As International Women’s Day approaches, data on the global women’s health market paints a mixed picture of the progress made ...

Kelly Grant and Chris Hannay answered reader questions on the rise of Ozempic and similar drugs in Canada, what experts are ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...